ArticleThe Journal of pharmacology and experimental therapeutics2018

In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183.

Randy S Schrecengost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.